Phase
Condition
Collagen Vascular Diseases
Idiopathic Inflammatory Myopathies
Connective Tissue Diseases
Treatment
exploration
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Woman or man> 18 years,
Signature of informed consent,
Muscle biopsy for suspicion of recent inflammatory myopathy (<6 months) or forexclusion of neuromuscular pathology.
Prospectively, following the results of the muscle biopsy, the subjects will divided into three groups meeting the following criteria:
"DM" group: DM according to the ENMC criteria;
"other inflammatory myopathy" group: polymyositis, autoimmune necrotizing myopathy,non-specific myositis or inclusion myositis according to the ENMC criteria;
Group "no neuromuscular pathology": i) myalgia and / or intolerance to exercise andii) normal neuromuscular examination, iii) no increase in blood creatine kinaselevel, iv) absence of electromyographic abnormality, v) histological Muscle mass.
Exclusion
Exclusion Criteria:
Taking an immunomodulatory treatment within 6 months before inclusion,
Paraneoplastic form of the disease,
Presence of associated interstitial pneumonitis,
Neuromuscular pathology different from inflammatory myopathy,
Unbalanced cardiovascular disease,
Impossibility of giving the subject informed information (subject in an emergencysituation, difficulty in understanding the subject, ...),
Subject under safeguard of justice,
Subject under tutelage or under curators,
Pregnancy (positive pregnancy test)
Breastfeeding.
Study Design
Connect with a study center
Meyer
Strasbourg, 67000
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.